Articles On Telix Pharmaceuticals (ASX:TLX)

The ASX200 closed down 4.2% at 7,343 points in a $97B wipeout for the market. The Energy sector was decimated, down 7%, followed by Financials, down 5%, and Materials and Discretionary – both down 4.8%. In the Green Lynas Rare News...

ASX tanks 4pc, worst drop since may 2020 Gold, copper, Bitcoin hammered in global rout Abacus Storage King bursts up after receiving buyout proposal    The ASX has taken a big hit on Monday, dropping by 4% as it marked the worst one-day l...

The ASX 200 index is crashing on Monday following an equally brutal selloff on Wall Street on Friday. While it certainly is a tough time for ASX investors, it could also be one of the best buying opportunities we have had in years and an id...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ — Telix Pharmac...

The recent share market selloff has rattled investor confidence — but for those thinking long term, it could be a gift in disguise. When share prices drop across the board, it often has less to do with company fundamentals and more to do...

If you are looking for ASX 200 stocks to buy in April after recent weakness, then it could be worth listening to what analysts at Bell Potter are saying. That's because the broker has just revealed its favoured picks for the month ahead o...

Donald Trump exempts “pharmaceuticals” from his tariff blitz ASX device makers mull their US manufacturing plans as Ansell shares plunge Race and Imugene progress their early-stage oncology trials   Liberation Day has spared the pharmaceu...

If you're looking to invest in the next generation of ASX success stories, sometimes you need to look beyond the usual household names. While the big end of town offers stability, it's often the mid-caps and emerging leaders that deliver th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, April 2, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited...

Some investors contend Clinuvel’s mountain of $200 million of cash is excessive and amounts to a ‘lazy’ balance sheet The company argues the cash buffer protects it against unexpected adversities and – in any event – every cent will be nee...

I think it is fair to say that 2025 hasn't exactly started the way most investors were hoping. Trade tensions, market jitters, and a sharp selloff in growth and tech stocks have sent many ASX shares tumbling well off their highs. And while...

Despite a late upturn, the ASX 200 closed 0.38% in the red on Thursday Blame factor 1: Trump and his 25% US auto import tariffs, set to come into play early April Blame factor 2: A Wall Street tech rout, which Trump had a hand in, too   ...

A cabal of ASX drug developers has defied the US gloom The healthcare jury’s out on new FDA head Dr Marty Makary Emvision’s Emu trial takes flight Amid the downbeat narrative about US healthcare policy and cuts to funding agencies, a ‘Mag...

The team at Bell Potter has been busy running the rule over the healthcare sector and has picked out a number of stocks that it believes are attractive options right now. Let's see what the broker is recommending investors buy now: Clinuve...

Highlights: FDA approval for a new imaging agent by Telix Pharmaceuticals influences discussions across market sectors. Resource industry undergoes shifts with notable divestments and operational challenges due to climatic condit...

The ASX has been trading flat at around 7,922 points on Friday. Staples has been the best-performing sector, up 3%, followed by Industrials and Utilities, both up 0.5%. Health Care has been the worst-performing, down 0.6%, followed by...

Highlights:  US Markets Retreat: S&P 500 erased early gains, closing slightly lower amid a lack of clear market direction.  Central Banks in Focus: The Bank of England, Sweden, and Taiwan maintained interest rates, while Switzerlan...

S&P/ASX 200 Index (ASX: XJO) healthcare stock Telix Pharmaceuticals Ltd (ASX: TLX) is marching higher today. Shares in the diagnostic and therapeutic product developer closed yesterday trading for $27.80. In morning trade on Friday, sh...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have slipped by around 11% from their former highs of $31 apiece since February. This isn't a Telix-only issue. The S&P/ASX 200 Index (ASX: XJO) is also down 5% this past month. This comes...

It was a return to red ink for the S&P/ASX 200 Index (ASX: XJO) this Wednesday, as investors lost the steam that had been powering a recovery over the past few trading days. By the time trading w...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are pointing to another down day as traders take risk off the table ahea...

Despite the current political upheaval, the US health sector remains the first port of call for most biotechs FDA approvals have sparked one-day share surges of as much as 500% Several ASX companies await do-or-die FDA approvals Despite r...

Telix Pharmaceuticals’ Brazilian win marks its first foray into the South American market Orthocell gains approval to sell its dental guided bone regeneration product in Singapore Sigma Healthcare: great prospects, a pity about the valuati...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ — Teli...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A fall in airfares assisted a lower-than-expected February US Core CPI print (pre-ta...

S&P/ASX 200 Index (ASX: XJO) share Telix Pharmaceuticals Ltd (ASX: TLX) is slipping today. Shares in the diagnostic and therapeutic product developer closed yesterday trading for $26.61. In morning trade on Wednesday, shares are swappi...

Healthcare analysts say Neuren shares should be worth more than double what they are Biotech sector retreats in February, despite some record results Dimerix pockets $3.2 million payment from Japanese partner   Some healthcare analysts be...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., March 4, 2025 /PRNewswire/ — Telix P...

ASX 200 healthcare share Telix Pharmaceuticals Ltd (ASX: TLX) fell 9.4% to an intraday low of $27.52 as the market digested news of a $118 million off-market trade by the co-founders. The radiopharmaceutical company's CEO, Dr. Christian...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 0.75% to 8,205.8 points. Four ASX shares that are falling more than most today are l...

Highlights: Karoon Energy strengthens its operational framework with an asset acquisition for its Brazil-based project. Qantas announces a dividend reinstatement, reflecting financial recovery in the aviation sector. Fluctuations...

Good afternoon and welcome to the Thursday edition of Market Close, I’m Jonathon Davidson. It was a somewhat happier day as Australian icon Qantas paid its first dividend in years and household name Coles proved to be consistently growing....

Highlights  Strong Start: ASX opens higher, driven by consumer staples and aviation sectors.  Corporate Moves: Notable stock movements include (ASX:COL), (ASX:QAN), (ASX:RHC), and (ASX:IDP).  Tech Sector Volatility: Nvidia’s earnings...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are signalling yet anolther uninspiring, downbeat session lays ahead for...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Feb. 26, 2025 /PRNewswire/ – Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are suggesting another cautious, slightly weaker opening for the ASX tod...

Like London buses, takeovers tend to come in a rush Mayne Pharma had struggled for years, but its performance was improving Takeovers in the ASX biotech sector have been few and far between The ‘London’ Bus theory goes that if one takeove...

Right now, I own Pro Medicus Ltd (ASX: PME) shares, Resmed CDI(ASX: RMD) shares and Telix Pharmaceuticals Ltd (ASX: TLX) shares, and previously owner Xero Ltd (ASX: XRO) shares. This article explains why I own PME, RMD and TLX, and some of...

S&P/ASX 300 Index (ASX: XKO) shares are currently down 0.66% to 8,185.70 points. Meantime, several companies in the index have hit new share price highs today. ASX 300 shares setting new price records on Tuesday Telix Pharmaceu...

The ASX is cruising along in 2025, extending a solid run for the S&P/ASX 200 Index (ASX: XJO). In the past year, it has climbed 655 points, or more than 8.5%. According to the experts, investors searching for shares with even greate...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Australian shares are set to open lower following a choppy session on Wall Street, a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AX1)) - Accen...

It's been a wild start to the trading week this Monday for ASX investors. After taking a deep plunge at market open this morning, the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 stocks have since recovered. The index has currently bro...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

Telix expects three more US product approvals this year Patrys switches to plan B Biotron’s do-or-die $500,000 capital raising   Analysts reckon Telix Pharmaceuticals (ASX:TLX) has only just started to reach its full potential, with three...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have been on an absolute tear over the past year, surging an incredible 175%. And according to the team at Bell Potter, this high-flying ASX 200 share may have even more room to run. This morning,...

It was a disappointing end to a horrid trading week for the S&P/ASX 200 Index (ASX: XJO). After falling every day this week, the ASX 200 capped off Friday's session with a 0.32% sell-down. Tha...

ASX hovers near one-month low, dragged by GYG and banks Domain soars on takeover bid RBA’s bullock admits slow rate hikes, while Alibaba rebounds   The ASX had a rough afternoon on Friday, with the market closing near its one-month low. D...

Highlights  ASX 200 edges lower as consumer discretionary stocks struggle.  Commonwealth Bank (ASX:CBA) and major banks face downward pressure.  Domain (ASX:DHG) surges on takeover speculation, while REA Group (ASX:REA) drops.  Th...

The S&P/ASX 200 Index (ASX: XJO) is rebounding slightly from yesterday's selloff. At the time of writing, the benchmark index is up 0.15% to 8,335.9 points. Four ASX shares that are rising more than most today are listed below. Here's...